Workflow
Euro
icon
Search documents
El arte no es útil, es vital | Amaia Salazar | TEDxUFV
TEDx Talks· 2025-06-26 15:02
[Música] El arte no sirve para nada, es inútil. Bellas artes no debería de ser una carrera, es un hobby. Y el arte no cura a nadie.¿Quiénes de los que estáis aquí presentes ha escuchado o dicho alguna vez estas afirmaciones. Yo las he escuchado tantas veces que por un momento me las creí. Pero esto cambió totalmente cuando vi a un paciente terminal pintar sus miedos en un lienzo.No me lo creí cuando vi a mi abuelo con cierto deterioro cognitivo recobrar la memoria a través de la música. Y no me lo creí cuan ...
¿Preparados para la era neurotecnológica? | José Manuel Muñoz | TEDxUFV
TEDx Talks· 2025-06-26 15:01
Quizá estéis un poco intrigados por lo que acabo de hacer, que es básicamente eh escribir un texto en una pantalla, en un dispositivo externo, utilizando para ello solamente mi actividad cerebral. Esto debo reconocer que es meramente un simulacro, pero en muchos menos años de los que quizá podamos sospechar, este tipo de cosas, como lo que acabo de hacer serán eh parte integral de nuestra vida cotidiana en sociedad. Y esto se será gracias a dispositivos como este que tengo en la mano, como el que acabo de u ...
Annovis to Attend the AAIC 2025 with Four Poster Presentations
Globenewswire· 2025-06-26 12:00
MALVERN, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced its senior management will attend the Alzheimer’s Association International Conference (AAIC), taking place July 27–31, 2025, in Toronto, Canada. The Company will present four scientific posters highlighting advan ...
Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA
Prnewswire· 2025-06-26 10:00
YUPELRI approved by China's NMPA as the first once-daily nebulized LAMA for maintenance treatment of COPD Approval triggers $7.5 million milestone payment from Viatris, with eligibility to receive further sales milestones and tiered royalties on net sales in China Theravance Biopharma incurs no commercial costs in China; Viatris is responsible for the launch and commercializationDUBLIN, June 26, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today a ...
Former MI6 Chief: Iran Problem Not Going Away
Bloomberg Television· 2025-06-25 15:22
Article five. Is it reliable. Can we rely on it. What is NATO's purpose at the moment if we can't rely on it.Well, Article VI's been there since 1949. It held the Soviet Union at bay during the Cold War. There wasn't an absolute guarantee.It's still a decision to be taken by each country when they as to what they do in response to a threat. But I think it has been very important. It has been a question now because of President Trump is is taking a more so transactional approach to this.Will he or won't he. ...
You Are What You Think | Thomas Kuchenbrod | TEDxHarmony Science Academy Dallas High
TEDx Talks· 2025-06-25 15:20
[Music] [Music] Massive transformation often follows periods of extreme stress. That is because change becomes necessary. For me, that moment occurred as a teenager.After my first semester of playing college baseball, I found myself in a hospital room diagnosed with the doctors told me was an incurable autoimmune disease. My prognosis was poor and there's a lot of uncertainty around my future. But I innately knew one thing.To get better, I had to change. What I soon found out was all the changes I would go ...
Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
Globenewswire· 2025-06-25 12:00
Efficacy and Safety of Setmelanotide in Acquired Hypothalamic Obesity: Results from a Double- Blind, Multicenter, Placebo-Controlled, Randomized Phase 3 Trial July 12, 2025, 2:00 PM - 2:15 PM PT Christian Roth, M.D., Seattle Children's Research Institute, will present a poster detailing exit interviews gathered from 30 patients or caregivers located in the US with acquired hypothalamic obesity who participated in the Phase 3 TRANSCEND trial. Experiences and Observations with Acquired Hypothalamic Obesity: A ...
Wall Street Dealmaker Moelis 'Very Bullish' on Europe
Bloomberg Television· 2025-06-25 11:19
Keep your eyes on the long term. I'm very optimistic. I think the the problem with the world today is, you know, pessimism.Pessimists get the headlines. I mean, everybody trying to point out everything negative that can happen. But if you really look at this over a number of years instead of a number of hours or a number of days, I think the world's very optimistic. I mean, even what's happening in in the Middle East is you can look at it negative or you can look at it and say this is an opportunity for one ...
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
Globenewswire· 2025-06-24 20:05
CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that a poster highlighting the decentralized design and patient experience of its Phase 2 SUNRISE-PD clinical trial evaluating bezisterim (NE3107) in early Parkinson’s disease will be presented in poster session at the upcoming Adv ...
E se il cervello sognasse a occhi aperti? | MATTEO DE SIMONE | TEDxAngri
TEDx Talks· 2025-06-24 16:39
[Musica] [Musica] Buonasera. Buonasera. Grazie a tutti.È un onore per me essere qui e cercherò in questi in questi minuti di presentarvi la bellezza del di quello che ho trovato nel mio mondo. Avete mai pensato che il luogo più fantastico, più visionario, più irraggiungibile in realtà sia già dentro di noi. Eh, non è una galassia lontana, non è un'intelligenza artificiale, non è nemmeno un multiverso, ma è un cervello umano.Eh, io lo vedo ogni giorno, lo studio, lo tocco, lo opero. Io, come avete sentito, s ...